Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1982 1
1983 3
1984 1
1985 3
1986 4
1987 3
1988 4
1989 2
1990 4
1991 3
1992 3
1993 3
1994 1
1995 3
1996 3
1997 1
1998 3
1999 1
2000 2
2001 1
2002 2
2003 1
2004 2
2005 2
2006 3
2007 2
2009 3
2010 2
2011 2
2012 2
2013 2
2014 1
2015 1
2017 1
2018 1
2020 1
2021 2
2022 4
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Evidence for antibody as a protective correlate for COVID-19 vaccines.
Earle KA, Ambrosino DM, Fiore-Gartland A, Goldblatt D, Gilbert PB, Siber GR, Dull P, Plotkin SA. Earle KA, et al. Among authors: ambrosino dm. Vaccine. 2021 Jul 22;39(32):4423-4428. doi: 10.1016/j.vaccine.2021.05.063. Epub 2021 May 24. Vaccine. 2021. PMID: 34210573 Free PMC article.
Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial.
Bravo L, Smolenov I, Han HH, Li P, Hosain R, Rockhold F, Clemens SAC, Roa C Jr, Borja-Tabora C, Quinsaat A, Lopez P, López-Medina E, Brochado L, Hernández EA, Reynales H, Medina T, Velasquez H, Toloza LB, Rodriguez EJ, de Salazar DIM, Rodríguez CA, Sprinz E, Cerbino-Neto J, Luz KG, Schwarzbold AV, Paiva MS, Carlos J, Montellano MEB, de Los Reyes MRA, Yu CY, Alberto ER, Panaligan MM, Salvani-Bautista M, Buntinx E, Hites M, Martinot JB, Bhorat QE, Badat A, Baccarini C, Hu B, Jurgens J, Engelbrecht J, Ambrosino D, Richmond P, Siber G, Liang J, Clemens R. Bravo L, et al. Among authors: ambrosino d. Lancet. 2022 Jan 29;399(10323):461-472. doi: 10.1016/S0140-6736(22)00055-1. Epub 2022 Jan 20. Lancet. 2022. PMID: 35065705 Free PMC article. Clinical Trial.
Towards a population-based threshold of protection for COVID-19 vaccines.
Goldblatt D, Fiore-Gartland A, Johnson M, Hunt A, Bengt C, Zavadska D, Snipe HD, Brown JS, Workman L, Zar HJ, Montefiori D, Shen X, Dull P, Plotkin S, Siber G, Ambrosino D. Goldblatt D, et al. Among authors: ambrosino d. Vaccine. 2022 Jan 21;40(2):306-315. doi: 10.1016/j.vaccine.2021.12.006. Epub 2021 Dec 15. Vaccine. 2022. PMID: 34933765 Free PMC article.
Tracking the 2009 H1N1 influenza virus in the Italian region Campania.
Esposito C, Di Spirito A, Cuomo N, Di Nicuolo G, Flaminio G, Altamura F, Ambrosino D, Cantalupo F, Costa C, Pentimalli F, Tarro G. Esposito C, et al. Among authors: ambrosino d. J Cell Physiol. 2012 Jul;227(7):2813-7. doi: 10.1002/jcp.23030. J Cell Physiol. 2012. PMID: 21928341 Review.
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Lambert PH, Ambrosino DM, Andersen SR, Baric RS, Black SB, Chen RT, Dekker CL, Didierlaurent AM, Graham BS, Martin SD, Molrine DC, Perlman S, Picard-Fraser PA, Pollard AJ, Qin C, Subbarao K, Cramer JP. Lambert PH, et al. Among authors: ambrosino dm. Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25. Vaccine. 2020. PMID: 32507409 Free PMC article.
Management of persistent chylothorax.
Plume SK, Ambrosino D, Boyle W Jr, Miller D. Plume SK, et al. Among authors: ambrosino d. Lancet. 1981 Aug 22;2(8243):423. doi: 10.1016/s0140-6736(81)90871-0. Lancet. 1981. PMID: 6115192 No abstract available.
81 results